Ticker

Analyst Price Targets — NBP

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
March 16, 2026 3:40 pmAndres MaldonadoH.C. Wainwright$9.00$2.86StreetInsider H.C. Wainwright Reiterates Buy Rating on NovaBridge Biosciences (NBP) following FDA meeting feedback
October 27, 2025 10:53 amAndrew FeinH.C. Wainwright$7.00$4.52StreetInsider H.C. Wainwright Reiterates Buy Rating on I-Mab (IMAB)
October 3, 2025 10:17 amLeerink Partners$9.00$4.13TheFly I-Mab initiated with an Outperform at Leerink
September 10, 2025 5:29 pmNew Street$7.00$4.18TheFly BTIG says buy I-Mab amid 'misperceived' China risk
August 28, 2025 5:15 pmKumaraguru RajaLoop Capital Markets$8.00$4.25StreetInsider I-Mab (IMAB) PT Raised to $8 at Brookline Capital Markets

Latest News for NBP

NovaBridge Biosciences to Participate in September Investor Conferences

ROCKVILLE, Md., Aug. 27, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a global biotechnology company that identifies differentiated innovation and applies disciplined development, financing, and partnering strategies to create value, today announced that the Company's leadership will participate in the following investor conferences in September 2026: Conference…

GlobeNewsWire • Aug 27, 2026
NovaBridge Reports First Half 2026 Financial Results and Highlights Pipeline Momentum and Strategic Execution

ROCKVILLE, Md., Aug. 20, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a global biotechnology company that identifies differentiated innovation and applies disciplined development, financing, and partnering strategies to create value, today reported financial results for the six months ended June 30, 2026, and provided a business update. During the first half of 2026,…

GlobeNewsWire • Aug 20, 2026
NovaBridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026

ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a global biotechnology company that identifies differentiated innovation and applies disciplined development, financing, and partnering strategies to create value, today announced that it will hold a webcast on Thursday, August 20, 2026 at 9:00 AM ET/9:00 PM China Standard Time to discuss recent…

GlobeNewsWire • Aug 13, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for NBP.

No House trades found for NBP.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top